Sign Up to like & get
recommendations!
0
Published in 2025 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.31563
Abstract: THV is a standard treatment for elderly patients with severe AS, using either BE or self‐expanding (SE) THVs. While the Myval BE THV has demonstrated safety and efficacy, data on its latest iteration, the Octacor,…
read more here.
Keywords:
immediate early;
treatment;
octacor;
valve ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.70034
Abstract: Recently, Acurate neo2 (ACN2; Boston Scientific, US) and Sapien‐3 series (Edwards Lifesciences, US) were compared in the IDE trial failing to demonstrate non‐inferiority of ACN2. The Myval series (MyV), an alternative balloon‐expandable device, demonstrated non‐inferiority…
read more here.
Keywords:
self expandable;
balloon expandable;
myval;
comparison self ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4146472
Abstract: Introduction: Transcatheter aortic valve implantation (TAVI) has been growing rapidly. The Myval balloon-expandable (BE) valve is a novel valve used for treating patients with severe aortic stenosis. No previous meta-analysis has assessed the different outcomes…
read more here.
Keywords:
severe aortic;
one year;
myval;
stenosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of Pediatric Cardiology"
DOI: 10.4103/apc.apc_242_20
Abstract: Background : Transcatheter pulmonary valve implantation (TPVI) is a surgical alternative for correcting dysfunctional right ventricular outflow tract conduits in previously operated patients. MyVal transcatheter heart valve (THV) (Meril Life Sciences, India), a new transcatheter…
read more here.
Keywords:
ventricular outflow;
right ventricular;
mmhg;
valve ... See more keywords